Midwifing the vaccine: The When is visible but there’s much left to do on the Who and How

The big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine against a novel virus to be administered in the midst of a raging pandemic.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35eG8kf
via IFTTT